Testimonials

“Information and guidance gained through AdvaMed’s Emerging Growth Company conferences and complimentary calls helped my staff to stay on top of important developments and put me in touch with senior representatives from other companies in the industry.”
    -- Michael D. Dale, President & CEO, ATS Medical, Inc.

“We have been members of AdvaMed for several years and recently became more active as our implantable device for the treatment of neurological disorders has moved closer to commercialization. An important turning point for the future of our company happened after a phone conversation with AdvaMed. Working with other companies in the industry, we were able to get our disease state inserted in the language of the Remote Monitoring Bill that went to Capitol Hill. As a pre-revenue company, that could make a big difference in our future success."
    -- Rebecca L. Kuhn, Chief Financial Officer and Vice President, Finance and Administration, NeuroPace, Inc.

“Our one hour face-to-face meeting with AdvaMed executives addressed key questions that we had been debating for a number of months. As a non-U.S.based company, these answers saved us additional money that we would have had to spend on consultants. Membership has already paid for itself and we are only in the first quarter of the year.”
    -- Paul Mitchell, US Operations Director, Deltex Medical

“AdvaMed’s experts have worked closely with my staff to help forward important initiatives that are vital to the success of my company’s products in the pediatric device arena. Until now, the pediatric device market has not been adequately addressed by CMS and we needed a strong ally. Through AdvaMed’s help and AGA’s involvement in its Pediatric Device group, good progress is being made.”
    -- Franck Gougeon, President and CEO, AGA Medical Corporation

“Not only did AdvaMed highlight the impact on the proposed reimbursement cuts on our technology in meetings with CMS, HHS and Congress, but they also supported constructive solutions that we offered to the Medicare program that enabled CMS to modify its reimbursement calculation methodology favorably for our procedure.”
    -- Craig T. Davenport, Chairman and CEO, Endocare, Inc.

“MTLI seminars provide greatly useful information presented by experts in the field that can make companies, especially small ones, grow in leaps and bounds. I always look forward to attending their seminars.”
    -- Hani Kayyali, President, CleveMed

“Information and guidance I gained through active participation in AdvaMed Work Groups made a tremendous difference for my company. We are right in the same room with executives from the largest companies in the industry.”
    -- Stuart Randle, President & Chief Executive Officer, GI Dynamics